Jan Stenvang

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Tracer-assisted shotgun lipidomics (TASL): A quantitative workflow integrating stable-isotope tracing with global lipidome profiling.

Tracer-assisted shotgun lipidomics (TASL): A quantitative workflow integrating stable-isotope tracing with global lipidome profiling.

Journal: Analytica chimica acta
Published: January 02, 2026

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

Journal: BMC cancer
Published: June 15, 2025

Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Journal: International journal of molecular sciences
Published: February 19, 2025

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.

Journal: Frontiers in oncology
Published: January 09, 2025

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.

Journal: Investigational new drugs
Published: October 24, 2024

Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer.

Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer.

Journal: Annals of translational medicine
Published: September 15, 2022

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.

Journal: Molecular oncology
Published: September 22, 2021

New use for old drugs: Epirubicin in colorectal cancer.

New use for old drugs: Epirubicin in colorectal cancer.

Journal: Acta oncologica (Stockholm, Sweden)
Published: March 30, 2021

Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock.

Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock.

Journal: Biomolecules
Published: March 24, 2021

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

Journal: Frontiers in oncology
Published: February 18, 2021

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance.

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance.

Journal: Cancers
Published: February 09, 2021

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.

Journal: International journal of molecular sciences
Published: June 07, 2020
Showing 1-12 of 63

Last Updated: 09/26/2026